BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

OriGene Technologies 

9620 Medical Center Drive
Suite 200
Rockville  Maryland  20850  U.S.A.
Phone: 301-340-3188 or 888-267-4436 Fax: 301-340-9254


SEARCH JOBS



OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research.

OriGene also dedicates itself to the market of companion diagnostics and OriGene recently developed a line of Antibodies. UltraMAB™, the ultra-specific antibody for anatomic pathology. The specificity of UltraMABs ™have been tested against breakthrough technology High Density Protein MicroArray to ensure every UltraMAB™ only recognizes its own targets without cross reacting with other proteins. In addition, to UltraMAB™, OriGene provides TrueMAB™ mouse monoclonal antibodies for the research market. TrueMABs are developed against authentic protein antigens and have been validated extensively for various immunoassays


 Key Statistics


Email: custsupport@origene.com
Ownership: Private

Web Site: OriGene Technologies
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
SDIX (SDIX) and OriGene Technologies Complete Sale of SDIX Life Science Assets to OriGene 7/15/2013 10:01:38 AM    More...
SDIX (SDIX) Stockholders Approve Sale of Life Science Assets to OriGene Technologies 7/11/2013 10:18:11 AM    More...
OriGene Technologies to Acquire SDIX (SDIX)'s Life Science Business Assets 4/8/2013 10:42:47 AM    More...
SDIX (SDIX) Sells Life Science Assets to OriGene Technologies for $16 Million 4/8/2013 9:44:16 AM    More...
OriGene Technologies Raises $21.3 Million in Series C Funding 3/21/2013 9:14:58 AM    More...
OriGene Technologies Publishes Landmark Paper on Revolutionary Proteome Platform for Antibody Specificity Test 1/8/2013 10:37:01 AM    More...
The PROOF Centre of Excellence Partners With OriGene Technologies on Heart & Kidney Transplant Biomarker Program 7/20/2012 9:39:17 AM    More...
OriGene Technologies Announces the Release Specificity-Verified UltraMAB(TM) Antibodies 3/21/2012 9:00:29 AM    More...
The Week in Review: OriGene Technologies Acquires Zhongshan Biotech 3/19/2012 9:22:23 AM    More...
OriGene Technologies Announces the Acquisition of Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd, a Leading Chinese Pathology Reagent Company 3/13/2012 9:40:12 AM    More...
12345